Elmwood Wealth Management Inc. Boosts Stake in ARK Genomic Revolution ETF (BATS:ARKG)

Elmwood Wealth Management Inc. increased its stake in ARK Genomic Revolution ETF (BATS:ARKG) by 39.7% in the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 57,766 shares of the company’s stock after acquiring an additional 16,412 shares during the period. Elmwood Wealth Management Inc. owned about 0.10% of ARK Genomic Revolution ETF worth $1,479,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Brown Miller Wealth Management LLC boosted its holdings in shares of ARK Genomic Revolution ETF by 5.5% in the 3rd quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock worth $460,000 after purchasing an additional 933 shares in the last quarter. Dynamic Advisor Solutions LLC lifted its position in ARK Genomic Revolution ETF by 7.8% in the 3rd quarter. Dynamic Advisor Solutions LLC now owns 13,590 shares of the company’s stock worth $348,000 after buying an additional 989 shares during the last quarter. Sanctuary Advisors LLC purchased a new stake in ARK Genomic Revolution ETF in the second quarter worth approximately $222,000. Northwestern Mutual Wealth Management Co. grew its position in ARK Genomic Revolution ETF by 2.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 166,281 shares of the company’s stock valued at $3,904,000 after acquiring an additional 3,341 shares during the last quarter. Finally, Main Management ETF Advisors LLC raised its stake in shares of ARK Genomic Revolution ETF by 2.3% during the second quarter. Main Management ETF Advisors LLC now owns 2,754,610 shares of the company’s stock worth $64,678,000 after acquiring an additional 62,470 shares in the last quarter.

ARK Genomic Revolution ETF Stock Performance

Shares of ARKG traded up $0.92 during mid-day trading on Monday, reaching $24.79. The company’s stock had a trading volume of 2,750,901 shares. The stock’s 50 day moving average price is $25.39 and its two-hundred day moving average price is $25.34.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.